Welcome to the e-CCO Library!

P151 Can two different faecal calprotectin assays be used interchangeably in inflammatory bowel disease treatment?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

E. Van Wassenaer MD1, K. Diederen1, A. Kindermann1, E.M.M. van Leeuwen2, G.R. D’Haens3, M.A. Benninga1, B.G.P. Koot1

Created: Thursday, 30 January 2020, 10:12 AM
P151: Assessing comprehensive remission for Ulcerative Colitis in clinical practice: International consensus recommendations
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schreiber, S.W.(1)*;Danese , S.(2);Dignass, A.(3);Domènech , E.(4);Fantini , M.(5);Ferrante, M.(6);Halfvarson, J.(7);Hart, A.(8);Magro, F.(9);Lees, C.(10);Leone, S.(11);Pierik, M.(12);Field, P.(13);Schofield, H.(13);Peyrin-Biroulet , L.(14);
Created: Friday, 14 July 2023, 10:48 AM
P151: Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohnメs disease of the small bowel in the biological era
Year: 2018
Source: ECCO '18 Vienna
Authors:

M. Rottoli1*, C. Vallicelli1, M. Melina1, C.A. Manzo1, P. Gionchetti2, F. Rizzello2, L. Boschi1, M. Di Simone1, G. Poggioli1

Created: Thursday, 21 February 2019, 9:14 AM
P151: Rationalizing colonoscopy utilization for Inflammatory bowel disease diagnosis: time to reset the Calprotectin threshold to >600?
Year: 2022
Source: ECCO'22
Authors: Abdellah Ahmed, M.(1,3);Desoki, R.(1,2);Taylor, K.(4);Woodward, J.(1);Corbett, G.(1);Parkes, M.(1);
Created: Friday, 11 February 2022, 3:52 PM
P151: Risk factors for first intestinal surgery in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Novacek*1, W. Reinisch1, S. Reinisch1, C. Primas1, W. Eigner1, H. Vogelsang1, C. Dejaco1, L. Kazemi-Shirazi1, M. Niapir1, P. Mekhail1, N. Pedarnig2, H. Angermann2, T. Waldhör3

Created: Friday, 22 February 2019, 9:41 AM
P151: Spinal disorders in IBD patients 20 years after diagnosis. Results from the IBSEN study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Ossum A.*1,2, Palm Ø.3, Cvancarova M.4, Moum B.1,2, Høivik M.1

Created: Wednesday, 20 February 2019, 10:36 AM
P151: Ulcerative colitis patients with zinc deficiency are at higher risk for disease-related complications
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

S. S. Siva*1, D. T. Rubin1, G. Gulotta1, K. Wroblewski2, J. Pekow1

Created: Friday, 22 February 2019, 9:49 AM
P151: Validation of the MaRIA Score in pediatric patients.
Year: 2021
Source: ECCO'21 Virtual
Authors: Palomino Pérez, L.M.(1);Velasco Rodríguez-Belvis, M.(1);Sirvent Cerdá, S.I.(2);Vazquez Gómez , J.A.(1);Muñoz Codoceo, R.A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P152 Should professionals provide their patients with digital health training resources?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Echarri Piudo1, G. Molina Arriero1, M. Sierra Ausin2, M. Calvo Moya3, J.L. Pérez Calle4, R. Fraga Iriso1, M.C. Morete Pérez1, B. Botella Mateu5, V. Ollero Pena1, M. Enriquez Rodriguez1, P. Nos Mateu6, B. Castro Senosiain7, D. Martín Rodriguez5, N. Mancenido Marcos8, G-EducaEII of GETECCU

Created: Thursday, 30 January 2020, 10:12 AM
P152: Bowel ultrasound as an early monitoring tool to assess disease activity in Crohn’s disease patients after induction therapy with infliximab
Year: 2021
Source: ECCO'21 Virtual
Authors: Morão, B.(1);Nascimento, C.(1);Frias Gomes, C.(1);Gonçalves, T.(2);Castro, F.(2);Moreira, M.J.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Macedo, C.(5);Ferreira, M.(5);Cravo, M.(1);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P152: Faecal calprotectin 100 ug/g and 50 ug/g predict endoscopic and histologic remission: a prospective study in quiescent ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

H. Y. Shi*, F. K. Chan, A. Higashimori, A. Chan, J. Y. Ching, J. C. Wu, J. J. Sung, S. C. Ng

Created: Friday, 22 February 2019, 9:49 AM
P152: Fatty liver disease in IBD patients as a part of extraintestinal manifestations
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Atanassova*1, A. Georgieva2

Created: Friday, 22 February 2019, 9:41 AM
P152: Fertility and reproduction in a tertiary IBD centre: the Oxford experience
Year: 2018
Source: ECCO '18 Vienna
Authors:

L.H. Lee1*, L. Knutzen2, J. Hollis3, R. Palmer1, S. Keshav1, S. Travis1, L. Mackillop2, O. Brain1

Created: Thursday, 21 February 2019, 9:14 AM
P152: Impact of disease location on burden of illness in patients with moderate-severe Crohn’s disease: A real-world survey in the United States, France, Germany, Italy, Spain, and United Kingdom (5EU)
Year: 2022
Source: ECCO'22
Authors: Sikirica, M.(1);Lynch, J.(2);Kershaw, J.(3);Lukanova, R.(3);Baker, S.(3);Milligan, G.(3);
Created: Friday, 11 February 2022, 3:52 PM
P152: Reconsidering the prognostic value of traditional serologic antibodies in Crohn's disease – immunoglobulin classes to take the centre stage
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sipeki N.1, Norman G.L.2, Shums Z.2, Veres G.3, Lakatos P.L.4, Antal-Szalmas P.5, Papp M.*6

Created: Wednesday, 20 February 2019, 10:36 AM
P152: The prevalence of Thiopurine-methyltransferase and NUTD15 in patient with ulcerative colitis: a hospital-based study in central Taiwan
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wu, Y.H.(1)*;Chou, J.W.(2);Po, J.H.(1);Wang, C.P.(1); Cheng, K.S.(1);
Created: Friday, 14 July 2023, 10:48 AM
P153 Fertility rate in women with IBD is decreased compared with general population: first multicentre survey in the Czech Republic
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Duricova1,2, M. Bortlik1,2,3, Z. Kratka4, L. Slaba5, T. Kovarova4, M. Lukas1, M. Pfeiferova5

Created: Thursday, 30 January 2020, 10:12 AM
P153: Association between ustekinumab trough concentrations and clinical, biochemical, and endoscopic outcomes in patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Serra-Ruiz, X.(1)*;Claudia, H.D.G.(1);Mayorga Ayala, L.(1);Robles Alonso, V.(1);Céspedes Martínez, E.(1);Casellas, F.(1);Miarons, M.(2);Garcia-Garcia, S.(2);Pérez Martínez, Z.(1);Oller, E.(1);Borruel Sainz, N.(1);
Created: Friday, 14 July 2023, 10:48 AM
P153: IBD patients’ treatment preferences are heterogeneous, but largely affected by the avoidance of abdominal pain and side effects (P-POWER IBD study)
Year: 2021
Source: ECCO'21 Virtual
Authors: Louis, E.(1);Siegel, C.A.(2);James, B.(3);Heidenreich, S.(4);Krucien, N.(4);Ghosh, S.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P153: Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Ricken1, M. Schneider*1, F. Bantleon1, S. Velayutham1, D. Trapani1, J. Afonso2, F. Magro2, A. Abel1

Created: Friday, 22 February 2019, 9:41 AM